Updated Report on Gynecomastia and Risperdal
|Gynecomastia and Risperdal|
Janssen Pharmaceuticals Inc. is a subsidiary of Johnson and Johnson. Janssen Pharmaceuticals manufactures the antipsychotic drug, Risperdal, which at one time was prescribed more than any other antipsychotic in the United States.
Risperdal has been in the news a lot lately due to multiple lawsuits claiming the drug causes serious side effects, including gynecomastia. The claims are that Risperdal blocks dopamine and raises prolactin levels. The legal dispute is one of the longest in history against a pharmaceutical company.
In September of 2012, the first trial was held against Johnson and Johnson but on the first day the case was settled for an amount that was not made public. After the first settlement, 5 more were settled in 2012.
Multiple offers are coming through from attorneys throughout the United States, by television advertising and online, to represent any men who took the drug and developed gynecomastia as a result. It is stated that there is a settlement in progress that may pay out large awards. However, this is not a class action lawsuit. A class action lawsuit settles for one amount that is divided equally among all claimants. Instead, the suit is termed a Multidistrict Litigation (MDL). An MDL is where all claims are heard by one judge in one courtroom. Then each case is handled individually with each settlement negotiated by the plaintiff’s attorney, and may be based on the degree of injury.
To date, Johnson and Johnson have paid to the Department of Justice, 2.2 billion dollars due to a guilty plea by Janssen Pharmaceuticals for misbranding Risperdal.
The Philadelphia Court of Common Pleas now has over 1300 pending cases against Johnson and Johnson. In the meantime, there have been 3 bellwether trials. Bellwether trials give an indication of how juries react to testimony, and attorneys can use this information to help them negotiate future settlements.
The first bellwether case settled in February and due to the large settlement of 2.5 million dollars, made national news. The settlement went to a man who is 20 years old and had been taking the drug for autism since he was 8 years old. The second bellwether case went in favor of the defendant due to lack of sufficient evidence that Risperdal actually caused gynecomastia. Recently the third bellwether case went in favor of the plaintiff but the amount of the settlement was undisclosed.
Miguel Delgado, M.D. wants patients to know that different states have different statutes of limitation for filing a claim. If you have been injured by Risperdal, he advises that you seek a consultation by a Board Certified Plastic Surgeon, who specializes in gynecomastia, and perhaps legal representation.